http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID192643_PMID6120237

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103164951_AID192643_PMID6120237_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103435295_AID192643_PMID6120237_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103435288_AID192643_PMID6120237_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103438096_AID192643_PMID6120237_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103164961_AID192643_PMID6120237_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103435428_AID192643_PMID6120237_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103438332_AID192643_PMID6120237_VALUE7
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Dose required to induce at least 50% inhibition of the isoprenaline-induced effect, administered intravenously
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103435428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103435295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103438096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103164951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103164961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103435288
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID192643

Total number of triples: 19.